🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Katherine C. Kurnit

University of Chicago

ORCID: 0000-0003-3205-0128
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression”.

Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression

Cancer Cell(2025)10.1016/j.ccell.2025.06.004
N/A
0.474DataRank · unranked
16 citations

Hilary A. Kenny, Rahul Krishnan, Lucy Kelliher, Janna Heide, Leonhard Donle +23 more

Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer

Endocrinology(2023)10.1210/endocr/bqad071
N/A
0.368DataRank · unranked
7 citations

Eleonora Dondossola, Kaitlin J. Basham, Nathaniel R. Wilson, Omar Alhalabi, Jianjun Gao +7 more

High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.100987
N/A
0.241DataRank · unranked
4 citations

M. Steiner, Ricardo R. Lastra, S. John Weroha, John Cursio, Ernst Lengyel +3 more

Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival

International Journal of Gynecological Cancer(2022)10.1136/ijgc-2021-003340
N/A
0DataRank · unranked
12 citations

Bryan Fellman, Gordon B. Mills, Jessica L. Bowser, Su-Su Xie, Russell R. Broaddus +1 more

Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.025
N/A
0DataRank · unranked
12 citations

Silvana Pedra Nobre, Bryan Fellman, David A. Iglesias, Kristina Lindemann, Anuja Jhingran +7 more

Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer

Cancer Letters(2021)10.1016/j.canlet.2021.01.030
N/A
0DataRank · unranked
27 citations

Ashley Draisey, Rebecca C. Kazen, Christine Chung, Luan Phan, Jerry B. Harvey +5 more

PARP inhibition in the ovarian cancer patient: Current approvals and future directions

Pharmacology & Therapeutics(2020)10.1016/j.pharmthera.2020.107588
N/A
0DataRank · unranked
16 citations

Monica Avila, Emily Hinchcliff, Robert L. Coleman, Shannon N. Westin, Katherine C. Kurnit

Context-dependent environmental associations with endometrial cancer histotype and genotype

International Journal of Gynecological Cancer(2023)10.1136/ijgc-2023-004330
N/A
0DataRank · unranked
5 citations

Katherine C. Kurnit, L Turner, Russell R. Broaddus, Sanaa Nakad Borrego

CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomas

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.11.18.624183
N/A
0DataRank · unranked
1 citations

Sunthoshini Premsankar, Katherine C. Kurnit, Lilly F. Chiou, Emily M. Rabjohns, Hannah N. Lee +4 more

Endometrial carcinosarcoma without myoinvasion

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101971
N/A
0DataRank · unranked
1 citations

William A. Zammarrelli, Dimitrios Nasioudis, Sofia Gabrilovich, Ilaria Capasso, Roberto Berretta +22 more

The search for new therapeutic options for uterine carcinosarcoma

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.05.025
N/A
0DataRank · unranked
0 citations

Katherine C. Kurnit